Page last updated: 2024-09-02

fingolimod hydrochloride and Epithelial Neoplasms

fingolimod hydrochloride has been researched along with Epithelial Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Do, IG; Jeon, HK; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Ryu, JY; Song, SY; Yoon, G1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Epithelial Neoplasms

ArticleYear
Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
    International journal of cancer, 2015, Jul-01, Volume: 137, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Protein Kinase Inhibitors; RNA, Small Interfering; Sphingosine; Xenograft Model Antitumor Assays

2015
chemdatabank.com